Don't Ignore This Health Care Giant in the Making

A publication from [Stansberry Research] [Stansberry Research 20 years] [DailyWealth] Don't Ignore This Health Care Giant in the Making By Brian Tycangco, analyst, True Wealth Opportunities: China --------------------------------------------------------------- I vividly remember the waiting room at my parents' health clinic in Chinatown. It was small, dimly lit, and always smelled of bleach. There were two long sofas upholstered in a tacky blue leather fabric. At the end of each sofa was a small table with old editions of Time and Newsweek magazines, along with that day's edition of the Manila Bulletin. As a kid, I'd spend almost every Saturday there. I would call in patients who'd been waiting in that room, sometimes for hours. My mom was a pediatrician, and my dad was a general surgeon. So the waiting area was usually packed with children, adults, and elderly alike. I didn't mind the clinic. I could read all the comic books I wanted, help myself to the soda in the fridge, and even play pretend doctor with some of my dad's medical tools (the reflex hammer was my favorite). There was one rule I always had to follow, though... and that was to never actually go in the waiting room... --------------------------------------------------------------- Recommended Links: # ['How I Survived (And Thrived) Through the Pandemic Crash']( He's stuck in his house outside Albany, New York under orders to "shelter in place." So he decided to go on camera and spill the secret he used to retire at 52... sleep easy through the crisis... and even install a home sauna to make quarantine more comfortable. [It's a huge secret of our paid research and he just... gives it away, right here](. --------------------------------------------------------------- # ['Top Stock to Own' as Virus Shocks U.S. Markets]( The recent sell-off in global markets is alarming. But one man has found the perfect "super stock" chaos hedge... and this will surprise most Americans. [Click here to learn more](. --------------------------------------------------------------- I didn't ask why back then. The reason behind the rule only dawned on me once I became a parent myself. I realized that every time I visited the doctor, I was potentially exposing myself – along with my wife and kids – to a host of infectious diseases... the ones that others in the waiting room were likely carrying. This is the unpleasant reality of health care in many parts of the world – and particularly in China. And as a result, China is full of folks who are almost paranoid about their health. No, this doesn't mean they're calorie-counting health buffs. They're paranoid because, just like the country I grew up in, good health care doesn't come free in China. Their national health insurance coverage is woefully inadequate. So people who require a major operation or receive a cancer diagnosis... well, they're going to foot an enormous bill. It's part of the reason people in China save so much of their money. And it's why, as Chinese citizens become wealthier, an increasing number of them will buy private health insurance. It's also why at the slightest sign of a cough, fever, or cold, Chinese families make a beeline for the clinic. There's no way they'll risk getting sicker. That only makes it more difficult and expensive to get treated. Roughly 9 million Chinese patients visit the hospital each day. That means the number of Chinese going to see the doctor each month is almost equivalent to the entire U.S. population. Another 253 million were admitted into hospitals last year. Despite this, China spends much less on health care than other developed nations. In 2018, China spent nearly $850 billion on health care. That works out to just $600 per person. By contrast, the U.S. spent $3.6 trillion – or a little more than $11,000 per person. But that disparity is closing fast. Take a look... Since 2000, Chinese health care spending has been growing at a compound annual rate of 15.2%. That's three times faster than the spending growth in the world's largest health care market to date – the U.S. If the average Chinese citizen spent just half of what his American counterpart spent on health care each year, China's health care market would be double the size of the U.S. Of course, that's not going to happen overnight. But it tells you just how big this market can grow. No one's interested in investing in China right now... in health care especially. But don't let that cloud your judgment. China's health care sector is a giant in the making. And for long-term investors, it's an area of the markets you should consider owning now. Good investing, Brian Tycangco P.S. My colleague Steve Sjuggerud is following this story, too. And he shared a simple way to profit from it in the most recent issue of his True Wealth newsletter, which he released on Friday. If you're interested in Steve's favorite way to invest in this trend, and you'd like to learn more about True Wealth, [click here](. Further Reading Just last year, China launched the fastest and largest wireless network. With its economy returning to normal, this means China's online-services market could be a big winner in the coming years... Learn more here: [The Unexpected Winner of Today's Coronavirus Outbreak](. Exchange-traded funds are a powerful tool that can hold some of the biggest and best companies. They're consistently used by the most legendary investors around. And now, investors in China will have access to the same high-quality, professionally managed resources... [Read more here](. INSIDE TODAY'S DailyWealth Premium It's time to buy the 'Amazon of China'... E-commerce in China is taking off. For one of the companies leading the charge, it means huge growth potential. And it will likely continue to soar as it dominates its industry... [Click here to get immediate access](. Market Notes HIGHS AND LOWS NEW HIGHS OF NOTE LAST WEEK Amazon (AMZN)... [online-retail king]( Walmart (WMT)... "World Dominator" of discount retail Dollar General (DG)... [discount retailer]( Netflix (NFLX)... [online-streaming giant]( DocuSign (DOCU)... Software as a Service Okta (OKTA)... [identity-protection software]( Qualys (QLYS)... [cybersecurity]( Eli Lilly (LLY)... pharmaceuticals NEW LOWS OF NOTE LAST WEEK Not many... The market has been rallying from its recent lows. --------------------------------------------------------------- [Tell us what you think of this content]( [We value our subscribers’ feedback. To help us improve your experience, we’d like to ask you a couple brief questions.]( [Click here to rate this e-mail]( You have received this e-mail as part of your subscription to DailyWealth. If you no longer want to receive e-mails from DailyWealth [click here](. Published by Stansberry Research. You're receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberrycustomerservice.com. Please note: The law prohibits us from giving personalized investment advice. © 2020 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 or [www.stansberryresearch.com](. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry Research does not recommend or endorse any brokers, dealers, or investment advisors. Stansberry Research forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry Research (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.